Evidence map›Paper›PMID 27009828›Full record

ArticleChemical communications (Cambridge, England)2016

Towards "bionic" proteins: replacement of continuous sequences from HIF-1α with proteomimetics to create functional p300 binding HIF-1α mimics.

George M Burslem, Hannah F Kyle, Alexander L Breeze, Thomas A Edwards, Adam Nelson, Stuart L Warriner, Andrew J Wilson

Open access · hybridAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

George M BurslemSchool of Chemistry, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK and Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk.
Hannah F KyleAstbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK.
Alexander L BreezeAstbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK and Discovery Sciences, AstraZeneca R&D, Alderley Park, Cheshire, SK10 4TG, UK.
Thomas A EdwardsAstbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, UK.
Adam NelsonSchool of Chemistry, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK and Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk.
Stuart L WarrinerSchool of Chemistry, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK and Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk.
Andrew J WilsonSchool of Chemistry, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK and Astbury Centre for Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds, LS29JT, UK. a.j.wilson@leeds.ac.uk.
University of Leeds · GBInstitute of Structural and Molecular Biology · GBAstraZeneca (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using the HIF-1α transcription factor as a model, this manuscript illustrates how an extended sequence of α-amino acids in a polypeptide can be replaced with a non-natural topographical mimic of an α-helix comprised from an aromatic oligoamide. The resultant hybrid is capable of reproducing the molecular recognition profile of the p300 binding sequence of HIF-1α from which it is derived.

Indexed as

AmidesBinding SitesBiomimetic MaterialsBionicsE1A-Associated p300 ProteinHumansHydrocarbons, AromaticHypoxia-Inducible Factor 1, alpha SubunitModels, MolecularPeptidesProtein Conformation, alpha-HelicalAmidesE1A-Associated p300 ProteinEP300 protein, humanHydrocarbons, AromaticHypoxia-Inducible Factor 1, alpha SubunitPeptides

Identifiers

PMID27009828
PMCPMC4843846
OpenAlexW2312123473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.